These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 20497246

  • 1. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
    Yamazaki M, Fujii S, Murata Y, Hayashi R, Ochiai A.
    Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
    [Abstract] [Full Text] [Related]

  • 2. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM.
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [Abstract] [Full Text] [Related]

  • 3. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S, Ettl T, Kleinsasser N, Hartmann A, Reichert TE, Driemel O.
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
    Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O.
    Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
    Okabe M, Inagaki H, Murase T, Inoue M, Nagai N, Eimoto T.
    Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
    [Abstract] [Full Text] [Related]

  • 6. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P, Saito T, Hama S, Arifin MT, Kajiwara Y, Yamasaki F, Hidaka T, Sugiyama K, Kurisu K.
    Cancer; 2007 Mar 01; 109(5):949-56. PubMed ID: 17262828
    [Abstract] [Full Text] [Related]

  • 7. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.
    Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY.
    J Oral Pathol Med; 2003 Oct 01; 32(9):552-61. PubMed ID: 12969230
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S, Okabe M, Nagatsuka H, Hasegawa Y, Inagaki A, Ijichi K, Nagai N, Eimoto T, Yokoi M, Shimozato K, Inagaki H.
    J Oral Maxillofac Surg; 2009 Jul 01; 67(7):1432-41. PubMed ID: 19531414
    [Abstract] [Full Text] [Related]

  • 9. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF, Cheung AN.
    Histopathology; 2005 Mar 01; 46(3):307-13. PubMed ID: 15720416
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
    Qing J, Zhang Q, Wei MW, Guo ZM.
    Ai Zheng; 2006 Sep 01; 25(9):1138-43. PubMed ID: 16965658
    [Abstract] [Full Text] [Related]

  • 11. Prognostic relevance of cell proliferation in major salivary gland carcinomas.
    Suzzi MV, Alessi A, Bertarelli C, Cancellieri A, Procaccio L, Dall'olio D, Laudadio P.
    Acta Otorhinolaryngol Ital; 2005 Jun 01; 25(3):161-8. PubMed ID: 16450771
    [Abstract] [Full Text] [Related]

  • 12. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF, Williams GH.
    Clin Cancer Res; 2005 Apr 01; 11(7):2510-7. PubMed ID: 15814627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
    Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG.
    Cancer Res; 1994 Nov 01; 54(21):5675-82. PubMed ID: 7522962
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS, Bento MJ, Palmeira C, Lopes C.
    J Oral Pathol Med; 2009 Jul 01; 38(6):508-13. PubMed ID: 19317849
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis.
    Lequerica-Fernández P, Astudillo A, de Vicente JC.
    Anticancer Res; 2007 Jul 01; 27(5B):3661-6. PubMed ID: 17972532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The role of neck dissection in the eradication of salivary carcinomas].
    Lin GC.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 May 01; 26(3):137-9, 190. PubMed ID: 1652411
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin expression in salivary gland carcinomas.
    Bjørndal K, Larsen SR, Godballe C, Krogdahl A.
    J Oral Pathol Med; 2011 Jul 01; 40(6):451-5. PubMed ID: 20969634
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.
    Am J Surg Pathol; 2007 Nov 01; 31(11):1645-52. PubMed ID: 18059220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.